Drug Shortage Report for DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC

Last updated on 2019-12-17 History
Report ID 99547
Drug Identification Number 02329743
Brand name DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC
Common or Proper name Sodium Iodide 131
Company Name JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Market Status MARKETED
Active Ingredient(s) SODIUM IODIDE 131 I
Strength(s) 7400MBq
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 Capsule/Vial
ATC code V10XA
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-11-18
Estimated end date 2019-12-16
Actual end date 2019-12-16
Shortage status Resolved
Updated date 2019-12-17
Company comments Awaiting release of a component. DRAXIMAGE® Sodium Iodide I 131 Solution, USP Therapeutic, DIN# 02329778 is currently available and can be used as an alternative during shortage period.
Health Canada comments
Tier 3 Status No
Contact Address 16751 TRANS CANADA HWY
KIRKLAND, QUEBEC
CANADA H9H 4J4
Company contact information Hiba Soulaihi HSoulaihi@jubl.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-12-17 French Compare
v8 2019-12-17 English Compare
v7 2019-11-22 French Compare
v6 2019-11-22 English Compare
v5 2019-11-22 French Compare
v4 2019-11-22 English Compare
v3 2019-11-22 French Compare
v2 2019-11-22 French Compare
v1 2019-11-22 English Compare

Showing 1 to 9 of 9